Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/43624
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorCadavid Jaramillo, Angela Patricia-
dc.contributor.authorÁlvarez Gómez, Angela María-
dc.contributor.authorRua Molina, Diana Carolina-
dc.contributor.authorRodríguez Colorado, Carlos Mario-
dc.contributor.authorVelásquez Berrío, Manuela-
dc.contributor.authorAbrahams, Vikki M.-
dc.contributor.authorViana, Marta-
dc.date.accessioned2024-11-20T14:09:29Z-
dc.date.available2024-11-20T14:09:29Z-
dc.date.issued2021-
dc.identifier.citationRodríguez CM, Velásquez-Berrío M, Rúa C, Viana M, Abrahams VM, Cadavid AP, Alvarez AM. Antiphospholipid Antibodies From Women With Pregnancy Morbidity and Vascular Thrombosis Induce Endothelial Mitochondrial Dysfunction, mTOR Activation, and Autophagy. Front Physiol. 2021 Nov 29;12:706743. doi: 10.3389/fphys.2021.706743.spa
dc.identifier.urihttps://hdl.handle.net/10495/43624-
dc.description.abstractABSTRACT: Antiphospholipid syndrome (APS) is an autoimmune disease characterized by thrombosis and pregnancy morbidity (PM) obstetric events together with persistent high titers of circulating antiphospholipid antibodies (aPL). Several mechanisms that explain the development of thrombosis and PM in APS include the association of aPL with alterations in the coagulation cascade and inflammatory events. Other mechanisms disturbing cellular homeostases, such as mitochondrial dysfunction, autophagy, and cell proliferation, have been described in other autoimmune diseases. Therefore, the objective of this study was to investigate the impact of aPL from different patient populations on endothelial cell mitochondrial function, activation of the mammalian target of rapamycin (mTOR) and autophagy pathways, and cellular growth. Using an in vitro model, human umbilical vein endothelial cells (HUVECs) were treated with polyclonal immunoglobulin G (IgG) purified from the serum of women with both PM and vascular thrombosis (PM/VT), with VT only (VT), or with PM and non-criteria aPL (seronegative-obstetric APS, SN-OAPS). We included IgG from women with PM without aPL (PM/aPL-) and healthy women with previous uncomplicated pregnancies (normal human serum, NHS) as control groups. Mitochondrial function, mTOR activation, autophagy, and cell proliferation were evaluated by Western blotting, flow cytometry, and functional assays. IgG from women with PM/VT increased HUVEC mitochondrial hyperpolarization and activation of the mTOR and autophagic pathways, while IgG from patients with VT induced endothelial autophagy and cell proliferation in the absence of elevated mTOR activity or mitochondrial dysfunction. IgG from the SN-OAPS patient group had no effect on any of these HUVEC responses. In conclusion, aPL from women with PM and vascular events induce cellular stress evidenced by mitochondrial hyperpolarization and increased activation of the mTOR and autophagic pathways which may play a role in the pathogenesis of obstetric APS.spa
dc.format.extent11 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherFrontiers Research Foundationspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by/2.5/co/*
dc.titleAntiphospholipid Antibodies From Women With Pregnancy Morbidity and Vascular Thrombosis Induce Endothelial Mitochondrial Dysfunction, mTOR Activation, and Autophagyspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGrupo de Investigación en Trombosisspa
dc.publisher.groupGrupo Reproducciónspa
dc.identifier.doi10.3389/fphys.2021.706743-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1664-042X-
oaire.citationtitleFrontiers in Physiologyspa
oaire.citationstartpage1spa
oaire.citationendpage11spa
oaire.citationvolume12spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by/4.0/spa
oaire.fundernameUniversidad de Antioquia. Vicerrectoría de investigación. Comité para el Desarrollo de la Investigación - CODIspa
dc.publisher.placeLausana, Suizaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsAnticuerpos Antifosfolípidos-
dc.subject.decsAntibodies, Antiphospholipid-
dc.subject.decsCélulas Endoteliales-
dc.subject.decsEndothelial Cells-
dc.subject.decsAutofagia-
dc.subject.decsAutophagy-
dc.subject.decsSíndrome Antifosfolípido-
dc.subject.decsAntiphospholipid syndrome-
dc.subject.decsEnfermedades Autoinmunes-
dc.subject.decsAutoimmune Diseases-
dc.subject.decsComplicaciones del Embarazo-
dc.subject.decsPregnancy Complications-
dc.identifier.urlhttp://www.frontiersin.org/physiology/archivespa
dc.description.researchgroupidCOL0010421spa
dc.description.researchgroupidCOL0007631spa
oaire.awardnumber2015-7448spa
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D017152-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D042783-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D001343-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D016736-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D001327-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D011248-
dc.relation.ispartofjournalabbrevFront. Physiol.spa
oaire.funderidentifier.rorRoR:03bp5hc83-
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
CadavidAngela_2021_Antiphospholipid_Antibodies_Women.pdf975.63 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons